Effects of flunixin meglumine or etodolac treatment on mucosal recovery of equine jejunum after ischemia
Authors:
- B. Osbone WilderBWB. Osbone Wilder
- Karen M. YoungKYKaren M. Young
- Anthony T. BlikslagerABAnthony T. Blikslager
- 1 June 2004
- journal article
- research article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 65 (6) , 761-769
Abstract
Objective—To examine the effects of flunixin meglumine and etodolac treatment on recovery of ischemicinjured equine jejunal mucosa after 18 hours of reperfusion. Animals—24 horses. Procedure—Jejunum was exposed to 2 hours of ischemia during anesthesia. Horses received saline (0.9% NaCl) solution (12 mL, IV, q 12 h), flunixin meglumine (1.1 mg/kg, IV, q 12 h), or etodolac (23 mg/kg, IV, q 12 h). Tissue specimens were obtained from ischemic-injured and nonischemic jejunum immediately after ischemia and 18 hours after recovery from ischemia. Transepithelial electric resistance (TER) and transepithelial flux of tritium-labeled mannitol measured mucosal permeability. Denuded villous surface area and mean epithelial neutrophil count per mm2 were calculated. Western blot analysis for cyclooxygenase (COX)-1 and -2 was performed. Pharmacokinetics of flunixin and etodolac and eicosanoid concentrations were determined. Results—Ischemic-injured tissue from horses treated with flunixin and etodolac had significantly lower TER and increased permeability to mannitol, compared with that from horses treated with saline solution. Epithelial denudation after ischemia and 18 hours after recovery was not significantly different among treatments. Both COX-1 and -2 were expressed in ischemic-injured and nonischemic tissues. Ischemia caused significant upregulation of both COX isoforms. Eicosanoid concentrations were significantly lower in tissues from flunixin and etodolac-treated horses, compared with that from horses treated with saline solution. Conclusions and Clinical Relevance—Flunixin and etodolac treatment retarded recovery of intestinal barrier function in jejunal mucosa after 18 hours of reperfusion, whereas tissues from horses treated with saline solution recovered baseline values of TER and permeability to mannitol. (Am J Vet Res 2004;65:761–769)Keywords
This publication has 44 references indexed in Scilit:
- Effects of non‐steroidal anti‐inflammatory drugs on cyclo‐oxygenase and lipoxygenase activity in whole blood from aspirin‐sensitive asthmatics vs healthy donorsBritish Journal of Pharmacology, 2002
- Persistent accumulation of cyclooxygenase-1—expressing microglial cells and macrophages and transient upregulation by endothelium in human brain injuryJournal of Neurosurgery, 2002
- The role of cyclooxygenase inhibitors in repair of ischaemic‐injured jejunal mucosa in the horseEquine Veterinary Journal, 2000
- Expression of cyclooxygenase 1 and 2 by human gastric endothelial cellsGut, 1999
- Expression of the Cyclooxygenase-2 Gene in Gastric EpitheliumJournal of Clinical Gastroenterology, 1997
- Gastroduodenal mucosal defenseCurrent Opinion in Gastroenterology, 1996
- Etodolac Clinical PharmacokineticsClinical Pharmacokinetics, 1994
- Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healingThe Lancet, 1990
- Bioavailability studies with etodolac in dogs and manBiopharmaceutics & Drug Disposition, 1984
- The Metabolic Disposition of Etodolac in Rats, Dogs, and ManDrug Metabolism Reviews, 1981